Table 2.
Distribution of hemoglobin levels in both groups.
| Dialysis modality | Hemoglobin level | n | PTH (pmol/L) | Using statins (%) | Using ACEi/ARB (%) |
|---|---|---|---|---|---|
|
| |||||
| PD diabetic patients (n=24) | Hb<100 g/L | 4 (16.6%) | 22.2 | 12.5 | 45.5 |
| Hb 100–120 g/L | 17 (70.8%) | 37.5 | 69.2 | 67.4 | |
| Hb>120 g/L | 2 (8.3%) | 51.5 | 50 | 100 | |
| PD nondiabetic (n=23) patients | Hb<100 g/L | 7 (30.4%) | 44.9 | 55.5 | 82.8 |
| Hb 100–120 g/L | 14 (60.8%) | 93.15 | 57.1 | 76.4 | |
| Hb>120 g/L | 2 (8.69%) | 72.46 | 50 | 75 | |
| HD diabetic (n=30) patients | Hb<100 g/L | 8 (26.7%) | 51.2 | 85.7 | 46.7 |
| Hb 100–120 g/L | 18 (60%) | 31.6 | 88.8 | 73.5 | |
| Hb>120 g/L | 4 (13.3%) | 34.46 | 25 | 50 | |
| HD nondiabetic (n= 27) patients | Hb<100 g/L | 9 (33.3%) | 40.1 | 20 | 82.3 |
| Hb 100–120 g/L | 13 (48.8%) | 82.1 | 91.7 | 74.5 | |
| Hb>120 g/L | 5 (18.5%) | 58.7 | 83.3 | 60 | |
PD: Peritoneal dialysis, HD: hemodialysis, PTH, parathyroid hormone, ACEi: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker.